ZA843032B - Pharmaceutical compositions for treatment of seizure disorders - Google Patents

Pharmaceutical compositions for treatment of seizure disorders

Info

Publication number
ZA843032B
ZA843032B ZA843032A ZA843032A ZA843032B ZA 843032 B ZA843032 B ZA 843032B ZA 843032 A ZA843032 A ZA 843032A ZA 843032 A ZA843032 A ZA 843032A ZA 843032 B ZA843032 B ZA 843032B
Authority
ZA
South Africa
Prior art keywords
treatment
seizure disorders
pharmaceutical compositions
seizure
disorders
Prior art date
Application number
ZA843032A
Other languages
English (en)
Inventor
Nikolaus Seiler
Shakir Sarhan
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA843032B publication Critical patent/ZA843032B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA843032A 1983-04-29 1984-04-24 Pharmaceutical compositions for treatment of seizure disorders ZA843032B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838311804A GB8311804D0 (en) 1983-04-29 1983-04-29 Treatment of seizure disorders and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA843032B true ZA843032B (en) 1984-11-28

Family

ID=10541938

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA843032A ZA843032B (en) 1983-04-29 1984-04-24 Pharmaceutical compositions for treatment of seizure disorders

Country Status (15)

Country Link
US (1) US4540582A (xx)
EP (1) EP0124091B1 (xx)
JP (1) JPS59206309A (xx)
AT (1) ATE48759T1 (xx)
AU (1) AU563291B2 (xx)
CA (1) CA1228818A (xx)
DE (1) DE3480764D1 (xx)
DK (1) DK160805C (xx)
GB (2) GB8311804D0 (xx)
GR (1) GR81966B (xx)
IE (1) IE57286B1 (xx)
IL (1) IL71650A (xx)
NZ (1) NZ207962A (xx)
PT (1) PT78492B (xx)
ZA (1) ZA843032B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013764A1 (en) * 1992-01-10 1993-07-22 Irina Alexeevna Komissarova Pharmaceutical preparation of antistress, stress-preventive and nootropic action
SI1077692T1 (en) * 1998-05-15 2004-10-31 Warner-Lambert Company Llc Amino acid stabilized gabapentin and pregabalin preparations and process for preparing the same
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6057368A (en) * 1998-08-05 2000-05-02 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
US6713497B1 (en) * 2003-03-17 2004-03-30 Brookhaven Science Associates, Llc Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals
EP1781279A2 (de) * 2004-06-11 2007-05-09 Egon Tech Präparat zur prophylaxe und therapie von stresszuständen, von funktionellen und organischen störungen des nervensystems und des stoffwechsels
MX2007008460A (es) * 2005-01-14 2007-07-25 Organon Nv Inhibidores de la reabsorcion de glicina para el tratamiento de dependencia a farmacos.
US20160151316A1 (en) * 2012-01-27 2016-06-02 Catalyst Pharmaceutical Partners Method of treating tourette's disorder with gaba-aminotransferase inactivators
US10226442B2 (en) * 2017-07-10 2019-03-12 Syneurx International (Taiwan) Corp. Lithium salts of N-substituted glycine compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1111433A (en) * 1965-08-25 1968-04-24 Zoja Lab Chim Farm A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions
US3960927A (en) * 1975-03-18 1976-06-01 Richardson-Merrell Inc. Olefinic derivatives of amino acids
FR2437834A1 (fr) * 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative

Also Published As

Publication number Publication date
DK213484A (da) 1984-10-30
GB8410504D0 (en) 1984-05-31
DK160805B (da) 1991-04-22
JPH0527606B2 (xx) 1993-04-21
GR81966B (xx) 1984-12-12
IL71650A (en) 1988-07-31
JPS59206309A (ja) 1984-11-22
EP0124091B1 (en) 1989-12-20
EP0124091A2 (en) 1984-11-07
US4540582A (en) 1985-09-10
ATE48759T1 (de) 1990-01-15
AU563291B2 (en) 1987-07-02
GB2138680B (en) 1986-05-21
GB2138680A (en) 1984-10-31
DE3480764D1 (de) 1990-01-25
DK213484D0 (da) 1984-04-27
PT78492B (en) 1986-06-11
AU2644384A (en) 1984-11-01
PT78492A (en) 1984-05-01
EP0124091A3 (en) 1987-10-07
IE57286B1 (en) 1992-07-15
IE841048L (en) 1984-10-29
NZ207962A (en) 1986-12-05
CA1228818A (en) 1987-11-03
IL71650A0 (en) 1984-07-31
GB8311804D0 (en) 1983-06-02
DK160805C (da) 1991-10-07

Similar Documents

Publication Publication Date Title
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
AU9137091A (en) Gaba and l-glutamic acid analogs for antiseizure treatment
DE69827149D1 (de) Agmatin für die behandlung neuropathischer schmerzen
NZ326754A (en) The use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene or salts thereof for the prophylaxis and treatment of sequelae of chronic reduced circulation in the brain in particular strokes and for neurodegenerative disorders
ES526297A0 (es) Un procedimiento para la preparacion de diarilpirazinas o triazinas
PL324330A1 (en) Do- and trivalent low-molecule selectin inhibitors
ZA843032B (en) Pharmaceutical compositions for treatment of seizure disorders
ZA933768B (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism.
IL140684A0 (en) Medicine nitrate salts
AU1529583A (en) Synergistic plant defoliat
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
IL132709A0 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
EP0155934A4 (en) Pharmaceutical compositions for the treatment of disorders caused by human drugs.
EP0104546A3 (en) Therapeutic dipeptides
ES8503922A1 (es) "procedimiento para la preparacion de un colirio".
CA2139353A1 (en) Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder
EP0273310A3 (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
ZA843489B (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives,processes for their preparation and their use in the combating of diseases of the central nervous system
DE3674971D1 (en) P-acylaminobenzamide.
MY116362A (en) Use of selegiline for the treatment of epileptic disorders
AU1940783A (en) Compositions for rust treatment
AU2038783A (en) Improved in-line valve for administering parenteral liquids